Lithium chloride
SIGMA/L9650 - Molecular Biology, ≥99%
Synonym: LiCl
CAS Number: 7447-41-8
Empirical Formula (Hill Notation): ClLi
Molecular Weight: 42.39
EC Number: 231-212-3
MDL Number: MFCD00011078
Linear Formula: LiCl
Product Type: Chemical
| anion traces | sulfate (SO42-): ≤0.01% |
| assay | ≥99% |
| cation traces | Ba: ≤0.003% |
| Fe: ≤0.001% | |
| heavy metals (as Pb): ≤0.002% | |
| K: ≤0.01% | |
| Na: ≤0.20% | |
| foreign activity | DNase, NICKase, RNase, protease, none detected |
| form | powder |
| grade | Molecular Biology |
| InChI | 1S/ClH.Li/h1H;/q;+1/p-1 |
| InChI key | KWGKDLIKAYFUFQ-UHFFFAOYSA |
| mp | 605 °C (lit.) |
| Quality Level | 200 ![]() |
| SMILES string | [Li+].[Cl-] |
| solubility | H2O: 100 mg/mL at 20 °C, clear, colorless |
| Application: | Lithium chloride has been used: • in the preparation of wash buffer for chromatin immunoprecipitation • in 3-(4,5-dimethylthiazol-2- • to treat aged myoblast as glycogen synthase kinase (GSK) inhibitor to analyse its effect on wingless/tailess (wnt) signaling |
| Application: | May be used to selectively precipitate RNA. |
| Biochem/physiol Actions: | Lithium chloride has the ability to block glycogen synthase kinase (GSK). It may also possess anti-inflammatory effects at low and non-toxic concentrations. |
| Packaging: | 100, 500 g in poly bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H315 - H319 |
| Precautionary statements | P264 - P270 - P280 - P301 + P312 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xn |
| Risk Statements | 22-36/37/38 |
| Safety Statements | 26-36/37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥99% |
| mp | 605 °C (lit.) |
| UNSPSC | 12352302 |


